Immorta-MAIT T cell clone EM-C5 Cell Line

The Immorta-MAITs are human mucosal-associated invariant T (MAIT) cells. Mucosal-associated invariant T (MAIT) cells are innate-like T cells that are found in blood, liver, lungs, and mucosa and are known to play a role in defence against bacterial and viral infections. These cell lines are clonal and were generated by single cloning methods from healthy […]

Contributors

Inventor Institute
Marielle Gold ; Erin Meerseier ; Irina Kurtz ; David Lewinsohn Oregon Health & Science University (OHSU), USA
Cat. #: 159688
Unit size: 1×10^6 cells / vial
Research Fields: Immunology
Organism: Human
Model: Immortalised Line
Growth properties: TRAV1-2 is expressed uniformly (determined by flow cytometry staining). This clone expresses CD4, CD8, CD161, and CD27 and can be classified as a double-positive thymocyte. This T cell clone binds the MR1/5-OP-RU tetramer but not MR1/6FP tetramer (negative control). Clone is MR1-restricted in its production of IFN-gamma by ELISPOT test, determined by its response to M. smegmatis-infected A549 cell line but not a M. smegmatis-infected MR1– A549 cell line.
Product description: The Immorta-MAITs are human mucosal-associated invariant T (MAIT) cells. Mucosal-associated invariant T (MAIT) cells are innate-like T cells that are found in blood, liver, lungs, and mucosa and are known to play a role in defence against bacterial and viral infections. These cell lines are clonal and were generated by single cloning methods from healthy thymus tissue not tumour tissue. MAITs have also been shown to potentially play a role in autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus.  This cell line expresses the MAIT T cell receptor alpha (TRAV1-2). EM-B11 stains with an MR1-tetramer loaded with a MAIT antigen 5-OP-RU and not control MR1-tetramer loaded with 6FP. This clone expresses CD4, CD8, CD161, and CD27. EM-C5 is a MAIT T cell clone which expresses a T-cell receptor (TCR) described in the image above.   There are 9 other Immorta-MAIT cell lines in this collection. Explore our ‘Related Tools’.  
Conditional: No
Production details: Generated by single cell isolation of MR1/5-OP-RU tetramer+ cells from a human thymus. Single cells were rapidly expanded into a T cell clone using antibody to CD3 (clone OKT3) and IL-2.
disease: Mycobacterium tuberculosis
Format: Frozen
Shipping conditions: Dry ice
Growth medium: These cell lines are not suitable for large-scale expansion following standard cell culture protocols. Following the recommended guidelines the cells should double after a week, after which cells are stable and useable for weeks. <br> <br> Upon receipt spin cells and resuspend them in 15ml of fresh media and add to T12.5 flask. Recommended media is RPMI supplemented with 10% FBS, L-Glut, gentamicin and 0.5ng/mL IL2. Incubate at 37 °C. Aspirate half the media and replace with fresh media every 3-4 weeks.

Images

View Gallery
A table to highlight the key differences between Immort-MAIT cell line clones. The first row relates to CD expression. The following rows show T cell receptor expression.

Related Tools for Cell lines

Cat. # Tool Name
151014 MCF7 AREc32 Cell Line Key Info View Tool
151425 TR146 Cell Line Key Info View Tool
151450 JIM3 Cell Line Key Info View Tool
151479 HCT 116 p300 KO [D10] Cell Line Key Info View Tool
151576 MEF RAF1 KO Cell Line Key Info View Tool

Related News

UM-UC-10 Cell Line. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC), UK.
Cell Lines

Popular cell lines now available only from CancerTools.org

Read More
Cell Lines

New cell lines: murine melanocyte and melanoblast cell lines from Dr. Elena Sviderskaya

Read More
Image Reference: 2x PTEN -/- mouse prostate cancer cell lines (MuCap system). Histology staining of syngraft tumours (Van Duijn et al., 2018).
Cell Lines

38 new prostate cancer cell lines

Read More

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.